About Cell division cycle-associated protein 7
Cell division cycle-associated protein 7 (CDCA7) is a protein
from Homo sapiens identified by UniProt accession
Q9BWT1, 371 residues long.
MolForge cross-references it against 0 known binders and
124 disease associations.
Target properties
| Protein name | Cell division cycle-associated protein 7 |
| UniProt accession | Q9BWT1 |
| Gene | CDCA7 |
| Organism | Homo sapiens |
| Length | 371 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (124)
Diseases linked to this target (Open Targets).
- ICF syndrome · score 0.73
- Abnormal intestine morphology · score 0.46
- immunodeficiency-centromeric instability-facial anomalies syndrome · score 0.46
- Recurrent respiratory infections · score 0.46
- mean corpuscular hemoglobin · score 0.41
- mean corpuscular volume · score 0.41
- breast carcinoma · score 0.39
- self reported educational attainment · score 0.38
- prostate carcinoma · score 0.38
- mean reticulocyte volume · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BWT1-F1 | alphafold | PREDICTED | 68.77 | — |
Amino-acid sequence (371 residues)
MDARRVPQKD LRVKKNLKKF RYVKLISMET SSSSDDSCDS FASDNFANTR LQSVREGCRT RSQCRHSGPL RVAMKFPARS TRGATNKKAE SRQPSENSVT DSNSDSEDES GMNFLEKRAL NIKQNKAMLA KLMSELESFP GSFRGRHPLP GSDSQSRRPR RRTFPGVASR RNPERRARPL TRSRSRILGS LDALPMEEEE EEDKYMLVRK RKTVDGYMNE DDLPRSRRSR SSVTLPHIIR PVEEITEEEL ENVCSNSREK IYNRSLGSTC HQCRQKTIDT KTNCRNPDCW GVRGQFCGPC LRNRYGEEVR DALLDPNWHC PPCRGICNCS FCRQRDGRCA TGVLVYLAKY HGFGNVHAYL KSLKQEFEMQ A
Explore Cell division cycle-associated protein 7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets